Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$1.02 - $3.23 $3,628 - $11,489
-3,557 Reduced 61.35%
2,241 $3,000
Q4 2023

Feb 06, 2024

SELL
$1.72 - $3.18 $1,147 - $2,121
-667 Reduced 10.32%
5,798 $16,000
Q2 2023

Aug 11, 2023

BUY
$3.6 - $5.25 $23,274 - $33,941
6,465 New
6,465 $28,000
Q2 2022

Aug 15, 2022

SELL
$2.6 - $6.14 $15,061 - $35,569
-5,793 Closed
0 $0
Q1 2022

Jun 30, 2022

SELL
$5.08 - $9.81 $2,159 - $4,169
-425 Reduced 6.83%
5,793 $33,000
Q3 2021

Oct 29, 2021

SELL
$76.53 - $110.43 $29,157 - $42,073
-381 Reduced 5.77%
6,218 $658,000
Q2 2021

Aug 16, 2021

BUY
$85.37 - $114.1 $244,926 - $327,352
2,869 Added 76.92%
6,599 $563,000
Q1 2021

May 13, 2021

SELL
$109.73 - $153.66 $38,954 - $54,549
-355 Reduced 8.69%
3,730 $428,000
Q4 2020

Feb 12, 2021

BUY
$79.58 - $152.45 $23,714 - $45,430
298 Added 7.87%
4,085 $571,000
Q3 2020

Oct 30, 2020

SELL
$66.43 - $90.99 $7,108 - $9,735
-107 Reduced 2.75%
3,787 $308,000
Q2 2020

Aug 10, 2020

BUY
$44.04 - $80.69 $171,491 - $314,206
3,894 New
3,894 $280,000
Q1 2020

May 13, 2020

SELL
$44.49 - $93.39 $173,688 - $364,594
-3,904 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$66.49 - $137.73 $55,386 - $114,729
833 Added 27.12%
3,904 $372,000
Q3 2019

Nov 13, 2019

BUY
$31.0 - $89.73 $95,201 - $275,560
3,071 New
3,071 $241,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $91.5M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.